Total planned funding: $320,426,387
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $81,829,204 |
Zambia | $54,757,802 |
Mozambique | $53,347,556 |
Kenya | $24,616,123 |
South Africa | $17,621,573 |
Vietnam | $12,518,988 |
Burundi | $9,645,063 |
Papua New Guinea | $6,709,004 |
Zimbabwe | $5,558,697 |
Indonesia | $5,389,394 |
India | $4,633,571 |
Tanzania | $4,200,000 |
South Sudan | $3,974,062 |
Côte d'Ivoire | $3,943,896 |
Asia Regional Program | $3,727,521 |
Botswana | $3,570,000 |
Ghana | $2,750,000 |
Caribbean Region | $2,519,565 |
Central America Region | $2,283,457 |
Malawi | $2,223,759 |
Angola | $2,222,878 |
Uganda | $2,002,161 |
Ethiopia | $1,850,536 |
Democratic Republic of the Congo | $1,800,000 |
Rwanda | $1,687,592 |
Dominican Republic | $1,418,747 |
Eswatini | $1,414,902 |
Namibia | $1,210,293 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Haiti | $290,043 |
Organizational Types
NGO | $320,426,387 |
Program Areas
Treatment | $99,270,559 |
Care | $84,414,218 |
Prevention | $76,785,377 |
Testing | $33,483,845 |
Governance and Systems | $26,472,388 |
Budget Codes
HTXS: Treatment: Adult Treatment | $88,499,822 |
HBHC: Care: Adult Care and Support | $36,351,118 |
HKID: Care: Orphans and Vulnerable Children | $35,178,697 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $34,943,007 |
HVCT: Testing: HIV Testing and Counseling | $33,483,845 |
HVOP: Sexual Prevention: Other Sexual Prevention | $30,700,386 |
PDTX: Treatment: Pediatric Treatment | $10,770,737 |
OHSS: Health Systems Strengthening | $9,415,046 |
HVSI: Strategic Information | $9,138,015 |
HLAB: Laboratory Infrastructure | $7,919,327 |
HVTB: Care: TB/HIV | $7,869,087 |
PDCS: Care: Pediatric Care and Support | $5,015,316 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,644,210 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,223,350 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,807,794 |
HMIN: Biomedical Prevention: Injection Safety | $320,033 |
HMBL: Biomedical Prevention: Blood Safety | $146,597 |
HTXD: Treatment: ARV Drugs | $0 |